Epigenetic modifiers as inducer of bioactive secondary metabolites in fungi
Biotechnology Letters · 2024
DOI: 10.1007/s10529-024-03478-z ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Letters, 2024. Verfasst von Vishal Sharma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fermentation & Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Fungi, Secondary Metabolism. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
Scientists are making efforts to search for new metabolites as they are essential lead molecules for the drug discovery, much required due to the evolution of multi drug resistance and new diseases. Moreover, higher production of known drugs is required because of the ever growing population. Microorganisms offer a vast collection of chemically distinct compounds that exhibit various biological functions. They play a crucial role in safeguarding crops, agriculture, and combating several infectious ailments and cancer. Research on fungi have grabbed a lot of attention after the discovery of penicillin, most of the compounds produced by fungi under normal cultivation conditions are discovered and now rarely new compounds are discovered. Treatment of fungi with the epigenetic modifiers has been becoming very popular since the last few years to boost the discovery of new molecules and enhance the production of already known molecules. Epigenetic literally means above genetics that actually does not alter the genome but alter its expression by altering the state of chromatin from heterochromatin to euchromatin. Chromatin in heterochromatin state usually doesn't express because it is closely packed by histones in this state. Epigenetic modifiers loosen the packing of chromatin by inhibiting DNA methylation and histone deacetylation and thus permit the expression of genes that usually remain dormant. This study delves into the possibility of utilizing epigenetic modifying agents to generate pharmacologically significant secondary metabolites from fungi.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fermentation & Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
- Department of Environment Studies, Panjab University, Chandigarh, 160014, India.
- Department of Biotechnology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara, Punjab, 144411, India.
- Fermentation & Microbial Biotechnology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India. sundeepjaglan@iiim.res.in.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. sundeepjaglan@iiim.res.in.
Zitieren
APA
Sharma, V., Panjgotra, S., Sharma, N., Abrol, V., Goutam, U., & Jaglan, S. (2024). Epigenetic modifiers as inducer of bioactive secondary metabolites in fungi. Biotechnology Letters. https://doi.org/10.1007/s10529-024-03478-z
Vancouver
Sharma V, Panjgotra S, Sharma N, Abrol V, Goutam U, Jaglan S. Epigenetic modifiers as inducer of bioactive secondary metabolites in fungi. Biotechnology Letters. 2024. doi:10.1007/s10529-024-03478-z
BibTeX
@article{Sharma2024,
author = {Sharma, Vishal and Panjgotra, Shivali and Sharma, Nisha and Abrol, Vidushi and Goutam, Umesh and Jaglan, Sundeep},
title = {Epigenetic modifiers as inducer of bioactive secondary metabolites in fungi},
journal = {Biotechnology Letters},
year = {2024},
doi = {10.1007/s10529-024-03478-z}
}
EUVIMED